Sort   by:  
 Page size 
To capture the changes in the lysosomal proteome upon TRPML1 activation, achieved using a small molecule agonist MLSA5, human cancer cells, with or without gene-editing, stably expressing TMEM192-mRFP-3xHA (Lyso-IP), were treated with MLSA5 and Lyso-IP samples were prepared and processed for TMT-MS ...
ORGANISM(S): Homo sapiens (Human) 
2025-04-22 | PXD054968 | Pride
Recently, endolysosomal cation channels have emerged as an attractive anti-cancer target: namely the mucolipin subfamily of transient potential receptors (TRPMLs), which comprises three isoforms – TRPML1 (MCOLN1), TRPML2 (MCOLN2), and TRPML3 (MCOLN3). TRPML1, the most intensively researched member o...
ORGANISM(S): Mus musculus (Mouse) 
2024-03-20 | PXD046212 | Pride
Sort   by:  
 Page size